180
Participants
Start Date
September 30, 2012
Primary Completion Date
December 31, 2015
Study Completion Date
July 31, 2016
Icotinib of routine dose
Icotinib of routine dose: 125 mg is administered orally three times per day.
Icotinib of high dose
Icotinib: 250 mg is administered orally three times per day.
RECRUITING
Sir Run Run Shaw Hospital, Hangzhou
RECRUITING
The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou
RECRUITING
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
ACTIVE_NOT_RECRUITING
Zhejiang Traditional Chinese Medical Hospital, Hangzhou
ACTIVE_NOT_RECRUITING
Zhejiang Hospital, Hangzhou
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
RECRUITING
Yinzhou People's Hospital, Ningbo
RECRUITING
Ningbo Medical Treatment Center Lihuili Hospital, Ningbo
RECRUITING
Taizhou Hospital of Zhejiang Province, Taizhou
RECRUITING
The First Affiliated Hospital of Wenzhou Medical College, Wenzhou
RECRUITING
Fujian Hospital for Chest Tumors & Tuberculosis Diseases, Fuzhou
RECRUITING
Fujian Provincal Hospital, Fuzhou
RECRUITING
Fujian Provincal Cancer Hospital, Fuzhou
RECRUITING
The second hospital of Xiamen City, Xiamen
RECRUITING
Hunan Provincal Cancer Hospital, Changsha
RECRUITING
The Second People's Hospital of Sichuan, Chengdu
Lead Sponsor
Betta Pharmaceuticals Co., Ltd.
INDUSTRY